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A B S T R A C T   
This study adopts a public value perspective to examine the eHealth services deployed by national and regional 
governments to contain the coronavirus (Covid-19) pandemic, including symptoms checkers, information portals 
and contact-tracing applications. We analyse 50 cases of eHealth applications adopted in 25 European Economic 
Area (EEA) and outline how these systems and technologies map against four dimensions of public value: user 
orientation, participation, legality and equity. Our findings reveal that the public value of the eHealth applications 
adopted in the context of the current pandemic is affected by both endogenous and exogenous factors that 
undermine their ability to improve the quality of healthcare services and social wellbeing. We conclude by 
suggesting areas for further research to address such factors and the trade-offs emerging between different di-
mensions of public value.   
1. Introduction 
The coronavirus (Covid-19) pandemic has spread across the globe 
with over 100 million confirmed cases and over 2.4 million deaths (at 
the time of writing). Covid-19 pandemic has put a huge strain on na-
tional health services and the global economy. To better control Covid- 
19 contagion and improve the delivery of healthcare services, the use of 
eHealth applications has been advocated by researchers and policy-
makers (UCLG, 2020; WHO, 2020; Ye, Zhou, & Wu, 2020). 
eHealth here refers to a wide range of e-government applications that 
use information and communication technologies (ICT) in the context of 
healthcare services (Oh, Rizo, & Enkin, 2005; WHO, 2020). Contact- 
tracing apps (CTAs), symptoms checkers and information portals are 
some examples of how eHealth can be deployed during a pandemic 
(Kretzschmar et al., 2020; Kristensen & Ruckenstein, 2018; Savona, 
2020; Storeng & de Bengy Puyvallée, 2021). Many of these applications 
have been adopted worldwide by local and national governments 
(eHealth Network, 2020, Hakmeh, Taylor, Peters, & Ignatidou, 2021; 
Kummitha, 2020), in collaboration with public healthcare and private 
technology providers. For example, in the UK, NHS Covid-19 app has 
been downloaded over 1.7 million times and prevented 600,000 in-
fections (Bradshaw & Venkataramakrishnan, 2021; Kelion, 2021). 
Despite their potential contribution to curtailing Covid-19 
contagion, these eHealth applications have attracted numerous criti-
cisms. For example, the deployment of CTAs has been opposed by those 
fearing that such short-term strategy could lead to a permanent state 
surveillance using personal data (Ferguson et al., 2020; Gasser, Ienca, 
Scheibner, Sleigh, & Vayena, 2020; Hakmeh et al., 2021; Kristensen & 
Ruckenstein, 2018). In addition, scholars have also highlighted the lack 
of accessibility of these applications by vulnerable members of the so-
ciety (McDonald, 2020; Savona, 2020). Overall, the debate and imple-
mentation of eHealth applications has been dominated by two opposing 
views. According to a techno-driven approach, the advantages of smart 
technologies justify their top-down imposition onto citizens. Conversely, 
the human-driven approach to smart technologies values the engage-
ment of citizens in the development and implementation of eHealth 
applications (Kummitha, 2020). These opposing views reflect different 
conceptions of technology as well as the ongoing trade-off between in-
dividual rights and public interest that has become evident after the 
imposition of restrictive measures to mitigate the impact of Covid-19 
pandemic (van Kolfschooten & de Ruijter, 2020). 
This paper aims to contribute to the ongoing debate on the imple-
mentation of eHealth applications in the context of a pandemic, by 
adopting a public value perspective (Moore, 1995). Public value theory 
has been widely employed to assess e-Government services, of which 
eHealth applications represent a specific variant (Scott, DeLone, & 
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Golden, 2016; Twizeyimana & Andersson, 2019). Drawing upon public 
value theory, we developed a conceptual framework that encompasses 
both utilitarian and social benefits expected from the use of ICT in 
healthcare sector. This framework is applied to analyse the eHealth 
applications adopted within the European Economic Area (EEA) to 
provide a comprehensive overview of the human-driven approaches to 
eHealth adopted in Western countries in tackling Covid-19 pandemic. 
Our qualitative comparison explores the features and functions of 
these applications to map the different strategies adopted so far and 
assess whether they are effectively designed to deliver and maximise 
public value. By focusing on both utilitarian and social benefits of 
eHealth applications, our analysis also sheds light on the potential trade- 
offs between individual rights and public interest emerging from the use 
of smart technologies in the context of reimagining healthcare strategies 
in a society that is increasingly becoming digitalised. 
Our paper is structured as follows: the concept of public value and 
the analytical framework used in this paper are discussed in Section 3 
after a brief review of the debate on eHealth services in the context of 
Covid-19 pandemic (Section 2). Section 4 briefly details the methodol-
ogy employed for the case study. Our analysis and findings are outlined 
in Section 5 followed by the discussion in Section 6. Section 7 then 
concludes with a set of recommendations for policymakers and future 
research. 
2. eHealth applications in the context of a pandemic 
eHealth is a type of e-government application, encompassing a wide 
range of devices and services that employ ICT to assist and enhance the 
provision of healthcare (Oh et al., 2005). ICT has long been used in the 
healthcare sector to facilitate access to medical information and pa-
tients’ data through, for example, online portals and smartcards. More 
recently, new digital technologies such as wearables and artificial in-
telligence have emerged as a potential gamechanger in the delivery of 
healthcare services (Firouzi et al., 2018). 
The extant literature has long emphasised the scope for using ICT to 
tackle health crises. For example, Li et al. (2012) stressed the importance 
of organisational preparedness in the development and adoption of 
eHealth services to deal with an influenza pandemic, while Timpka et al. 
(2014) explored the potential of eHealth systems to improve the sur-
veillance of infectious diseases. More recently, CTAs, using location data 
from smartphones to trace people who may have been in contact with 
infected patients, have been presented as a powerful tool to mitigate the 
inefficiency of traditional contact-tracing and minimise the spread of 
Covid-19 (Arakpogun, Elsahn, Prime, Gerli, & Olan, 2020; Kretzschmar 
et al., 2020). Furthermore, since Covid-19 was declared a pandemic, 
many governments in East Asian and European countries have invested 
in eHealth applications to manage various aspects of Covid-19. For 
example, alongside CTAs, symptoms checkers have been developed to 
help citizens to monitor their health conditions and early detection of 
Covid-19 cases. Various portals and apps have also been launched to 
disseminate information on the pandemic (eHealth Network, 2020; 
Storeng & de Bengy Puyvallée, 2021), while some governments in East 
Asia have used smartphone apps and wearables to monitor the location 
of patients and enforce lockdown measures (Hernández-Orallo, Man-
zoni, Calafate, & Cano, 2020; WHO, 2020). 
Whereas East Asia countries have followed a top-down and techno- 
driven approach that resulted into the adoption of eHealth applica-
tions to curtail the spread of Covid-19, their use in western democracies 
has been at the centre of public debate for several months (Kummitha, 
2020; Ye et al., 2020). Concerns have been raised over the implications 
of eHealth applications for data protection as these technologies record, 
transmit and store a wide range of personal data, including patient 
medical information and the movement of users and non-users (Savona, 
2020; van Kolfschooten & de Ruijter, 2020). Furthermore, it has been 
highlighted how inequalities in the access to connectivity and the lack of 
digital literacy may hamper the ability of certain social groups to take 
advantage of these applications (Arakpogun et al., 2020; McDonald, 
2020; Savona, 2020). Thereby, exacerbating stigma against marginal-
ised groups (such as migrants), and disproportionally affecting certain 
individuals that are already disadvantaged, including those unable to 
work from home (Davis, 2020; Klenk & Duijf, 2020). 
In their review of the current debate on the use of digital technolo-
gies to contain the spread of Covid-19, Savona (2020) highlighted the 
need for a more articulated and comprehensive reflection on the use of 
eHealth in the context of a pandemic. Indeed, previous studies have 
explored the implications of eHealth applications from a purely theo-
retical and conceptual standpoint, highlighting potential drawbacks and 
shortcoming in the design and implementation of eHealth strategies in 
response to the outbreak of Covid-19 (Arakpogun et al., 2020). 
While an empirical evaluation of the effects of eHealth applications 
in the current pandemic is not yet feasible given the fluidity of events, 
this paper aims to expand the research on this topic by mapping the 
strategies adopted across the EEA and assessing whether they are 
effectively designed to create public value. The latter provides a 
comprehensive sample of the eHealth initiatives adopted by Western 
democracies, thereby shedding light on the implications of the human- 
driven approach followed by these countries in the context of the cur-
rent pandemic (Kummitha, 2020). 
As explained in the following section, these case studies are assessed 
against several dimensions of public value, that reflect both the utili-
tarian and social benefits of eHealth applications. This approach is ex-
pected to produce a comprehensive understanding of the actual design 
and implementation of eHealth strategies, thereby overcoming some of 
the limitations identified in the extant research (Savona, 2020). 
Furthermore, the theory of public value provides a solid framework to 
explore the potential trade-off emerging between individual rights and 
public interest when smart technologies are used to contain the spread of 
a pandemic (Kummitha, 2020; van Kolfschooten & de Ruijter, 2020). 
3. Public values, ICT and healthcare 
The evaluation of ICT use in organisations is a central topic in the 
information systems (IS) literature (Rose, Persson, Heeager, & Irani, 
2015), but most of the frameworks that evaluate IS are underpinned by 
market logic, thereby emphasising values such as profitability and effi-
ciency (Grimsley & Meehan, 2007). These models are less applicable to 
study the implementation of IS within the public sector (Frisk, Bannister, 
& Lindgren, 2015), where the use of ICT goes beyond the narrow focus of 
profitability to include the achievement of social and political goals 
(Rose et al., 2015). 
Consistently, the analysis of e-government services, which are 
designed to achieve public interest rather than commercial purposes, 
has often been based on the theory of public value (Twizeyimana & 
Andersson, 2019). As Moore (2000, p.186) argues, value, as understood 
in the public domain, is about “the achievement of the political 
mandated mission of the organization and the fulfilment of the citizen 
aspiration that was more or less reliably reflected in that mandate”. 
Accordingly, from a public value perspective, the evaluation of public 
services goes beyond the focus on efficiency and effectiveness to 
encompass a wider range of values, which also reflect the contribution of 
the public sector to society and democracy (Bryson, Crosby, & Bloom-
berg, 2014; Jørgensen & Bozeman, 2007). By creating public value, e- 
government services are expected to both generate net benefits for the 
end-users and enhance the relationship between citizens and govern-
ments (Grimsley & Meehan, 2007; Seltsikas & O’Keefe, 2010). Conse-
quently, e-government has been assessed against its ability to generate 
both tangible (e.g., cost savings) and intangible outcomes (e.g., social 
inclusion) (Scott et al., 2016). 
The perspective of public value has also been applied to analyse 
eHealth services, which are e-government services employing ICT for 
the delivery of healthcare information and services to citizens. Bend 
(2004) measured the public value of eHealth applications against the 
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achievement of desired outcomes and the level of trust between citizens 
and healthcare providers. Svejvig, Schlichter, and Andersen (2012) 
adopted a broader perspective and considered how eHealth also affects 
the perceived quality of healthcare services among patients and em-
ployees. Other scholars have also argued that the evaluation of eHealth 
services should integrate the view of public value with that of social 
justice and include dimensions such as privacy, security, and account-
ability (Atherley, 2005; Hakmeh et al., 2021; Storeng & de Bengy 
Puyvallée, 2021). 
The evaluation of eHealth remains particularly challenging, due to 
the complex nature of healthcare services and the variety of stakeholders 
involved (Alalwany & Alshawi, 2008). However, the literature on the 
public value of e-government provides a solid theoretical foundation 
and a well-defined set of concepts that can be used to explore to what 
extent eHealth applications contribute to achieving the political man-
dates of public organisations and the aspirations of citizens. Accord-
ingly, the evaluation of eHealth applications in this paper is based on a 
novel framework (see Fig. 1) that combines concepts and dimensions of 
public value from three existing taxonomies. 
Firstly, the values associated by Jørgensen and Bozeman (2007) with 
the relationship between public administration and citizens (user 
orientation, participation, legality and equity) were integrated with the 
three overarching and overlapping dimensions (improved public ser-
vices, improved administration and improved social value) identified by 
Twizeyimana and Andersson (2019) in their review of the literature on 
public value and e-government. Secondly, the outcomes adopted by 
Scott et al. (2016) and the indicators listed by Twizeyimana and 
Andersson (2019) to specifically assess e-government services were 
mapped against these dimensions. As a result, our framework (Fig. 1) 
shows how different indicators, reflecting specific dimensions of public 
value, contribute to enhance public value by either improving admin-
istration, improving public services, or improving social value and 
wellbeing. 
User orientation is linked to the direct outcomes and services that 
eHealth services can provide to their end-users (Scott et al., 2016). Ac-
cording to Scott et al. (2016) and Twizeyimana and Andersson (2019), 
these outcomes can be assessed in terms of cost and time savings as well 
as higher degree of personalisation and control over the delivery of 
public services, better communication with public administration, and 
easier retrieval of information. Echoing the dimension of dialogue 
included in Jørgensen and Bozeman (2007), participation refers to the 
potential of ICT to enhance the involvement of citizens in policymaking 
(Scott et al., 2016). This can be evaluated against the degree of collab-
oration between governments and citizens, the level of transparency of 
the public sector, and the informedness of citizens (Twizeyimana & 
Andersson, 2019). Speaking of transparency, Alessandro, Lagomarsino, 
Scartascini, Streb, and Torrealday (2021) further highlights that trans-
parency in the public sector also increases the trustworthiness of 
governments. 
Furthermore, legality and equity reflect to what extent eHealth ser-
vices are compliant with individual rights, ensure an equal treatment of 
citizens and reduce inequalities in the access to healthcare services. 
These dimensions have not been thoroughly examined in the context of 
e-government (Scott et al., 2016; Twizeyimana & Andersson, 2019). Yet 
they recur as crucial issues in the literature on eHealth services 
(Atherley, 2005; Bend, 2004; Cashen, Dykes, & Gerber, 2004; Choi & 
DiNitto, 2013; Kearns, 2004) and in the public debate about eHealth 
applications developed in response to the pandemic, particularly the 
violation of individual rights and the exclusion of vulnerable social 
groups as indicated in Section 2. 
As observed by Twizeyimana and Andersson (2019) and represented 
in Fig. 1, there is an overlap between dimensions and indicators of public 
value. Some values are expected to enhance both the quality of public 
services, the efficiency of public administration and social well-being: 
for example, easier access to information improves the experience of 
single end-users but also benefits the society as a whole. This is in 
addition to reducing the time and cost of administrative processes. The 
values associated to legality and equity, instead, only concern the 
quality of public services and social well-being. The framework devel-
oped in Fig. 1 will be used to map how different eHealth services 
contribute to creating public value, considering both the social and the 
utilitarian benefits associated with the use of ICT to deliver public ser-
vices. By highlighting the potential overlap among different dimensions 
of public values, this framework is also expected to clarify the potential 
trade-offs between individual rights and public interest in the imple-
mentation of eHealth applications (de Lecuona & Villalobos-Quesada, 
2018; van Kolfschooten & de Ruijter, 2020). 
4. Methodology 
The analysis in this paper draws from the secondary data of 50 cases 
of eHealth applications adopted in 25 EEA countries1 (See Appendix 2). 
These EEA countries are developed economies and established de-
mocracies subject to the same regulations such as the General Data 
Protection Regulation (GDPR). However, they also display significant 
differences in terms of size, culture, and political environment. Conse-
quently, they provide a comparable yet heterogeneous sample to study 
the design and implementation of eHealth applications in Western 
countries during Covid-19 pandemic. 
Our analysis is also limited to government-to-citizen (G2C) applica-
tions, developed under the supervision or with the endorsement of 
public organisations. Although public values can also be fostered by 
non-public organisations (Bryson et al., 2014), limiting the scope of the 
analysis to the applications developed under the supervision of public 
organisation makes this comparison more systematic and consistent 
with the framework in Section 3, which considers eHealth as a form of e- 
government service. The case studies were identified through the 
consultation of multiple repositories, listing the eHealth applications put 
in place since the outbreak of Covid-19 (Bischoff, 2020; eHealth 
Network, 2020; Open government partnership, 2020). Data on the single 
cases were retrieved from the websites of the organisations offering 
these applications and from the app marketplaces where these appli-
cations can be downloaded, including Apple and Play Stores. Further 
information on the case studies was sourced from online news platforms 
(such as BBC News, Deutsche Welle, Financial Times) and online re-
positories (such as GitHub). Systematic analyses of press releases, FAQ 
sections and privacy statements were conducted to collect detailed in-
formation on the design and governance of these eHealth services. 
The analysis focused on several technical and organisational features 
that reflected the dimensions of public value described in Fig. 1. As 
detailed in Appendix 1, each dimension was explored through a set of 
questions, derived from the literature. As detailed in Appendix 2, these 
questions were then used to guide the analysis of the applications and to 
map them against the different dimensions included in the conceptual 
framework to assess whether their design is likely to create public value. 
5. Analysis and findings 
Consistent with Grimsley and Meehan (2007), the first step of the 
analysis was to map the outcomes expected and the services offered by 
these applications. As summarised in Table 1 (see Appendix 1 for de-
tails), two major outcomes were identified. Most of the eHealth 
1 At the time of writing, a further 7 applications were being developed or 
trialled within the EEA, but these have been excluded from the analysis because 
they are yet to be completed and made available to citizens. Consequently, our 
sample does not include cases from five EEA countries (Liechtenstein, 
Luxembourg, Malta, Romania, Slovakia) where eHealth applications are still 
under development. Sweden has also been omitted from this analysis because, 
at the time of writing, there are no plans to adopt eHealth applications to fight 
Covid-19 in this country. 
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applications developed within the EEA in response to Covid-19 aim to 
provide citizens with better access to medical information and care. 
Alternatively, smartphone-based apps have been adopted to prevent the 
spread of the virus through tracing the movements and contacts of their 
users or by monitoring the location of individuals. 
Twenty-two apps and websites have been developed to provide cit-
izens with updated information on the virus and the healthcare services 
locally available. In 16 cases, this functionality is combined with 
symptoms checkers that enable end-users to obtain a preliminary 
assessment of their health conditions and personal recommendations on 
the behaviours or medication to take. In five cases, eHealth applications 
have been developed to provide better treatments to those patients who 
tested positive but were not hospitalised. This outcome is pursued by 
equipping the patients with wearables that monitor their health condi-
tions (e.g., the case of HSE Covid-19 in Ireland and H-Casa in Italy) or by 
asking them to regularly record their symptoms on an app or a website 
(e.g., the case of TreCovid19 in Italy and Covidom in France). The data 
collected through these applications are shared with health pro-
fessionals that can take tailored actions or suggest specific medications. 
Wearables are also being used in Germany to collect data and monitor 
the health of those citizens voluntarily joining the Corona-datenspende 
Fig. 1. Analytical framework for analysing the public value of eHealth applications. 
Source: Developd by authors based on Jørgensen and Bozeman (2007), Scott et al. (2016) and Twizeyimana and Andersson (2019). 
Table 1 
Classification of the eHealth applications developed in EEA in response to Covid- 
19.  
eHealth applications for better access to 
healthcare information and care 
eHealth applications designed to contain 
the spreads of the virus 
22 apps and websites providing updated 
information on the disease and the 
healthcare services available 
20 apps that track the movements and 
record the contacts of their users 
26 apps and websites for checking 
symptoms 
3 smartphone-apps monitoring the 
location and behaviour of their users 
5 applications monitoring the health 
conditions of patients in self-isolation 
through multiple channels 
1 application monitoring the health 
conditions of voluntary citizens through 
wearables 
Source: Developed by authors using data from Appendix 2. 
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(literally, Corona data donation) programme. A similar initiative is 
under pilot in Liechtenstein, where 2000 biometric bracelets have been 
distributed to the local population. The data collected through these 
devices are expected to help health authorities to monitor and better 
predict the future spread of Covid-19. 
CTAs have been launched in 20 countries, but their implementation 
was under discussion in additional five EEA countries. In only three 
cases digital technologies have been used to monitor the behaviours of 
specific groups of citizens. In Poland and Lithuania individuals in 
quarantine are requested to prove evidence of their location through an 
app, which reports to the police those not complying with self-isolation. 
The government of Sardinia (a region in Italy), instead, requests those 
visiting the island to download (voluntarily) an app to record their 
arrival. 
Matching our case analysis with the proposed framework in Fig. 1, 
we identified several findings in relation to the user orientation of these 
applications. The comparison revealed that all the eHealth applications 
adopted across the EEA are available for free to end-users (Q1 in Ap-
pendix 1). The gratuitousness of these services is frequently emphasised, 
but it is not necessarily an advantage of eHealth applications. In fact, the 
offline services that they replace or complement (e.g., phone helplines 
and human contact tracing) are also available for free. Conversely, these 
applications may entail hidden costs for the end-users that are required 
to upgrade their digital devices or use their internet connection to access 
online services. 
In terms of time-savings, websites or apps providing medical infor-
mation, symptoms checkers and CTAs speed up the exchange of infor-
mation between citizens and health authorities (Q2a) by providing 
instant updates on the healthcare services available and the potential 
risk of contagion. Conversely, only health monitoring apps ensure timely 
access to healthcare services by triggering medical interventions as soon 
as the conditions of patients worsen (Q2b). In six cases, symptom 
checkers also speed up access to healthcare by enabling users to arrange 
an online consultation with their doctors. In two cases (ViruSafe in 
Bulgaria and Lazio Doctor in Italy), doctors can also contact their pa-
tients if the data collected through symptom checkers suggest the need 
for a medical intervention. 
Similarly, the analysis revealed that information retrieval is 
enhanced when the applications include a section with details on the 
contagion, its treatment, and the services available to citizens (Q3a). 
These functions are naturally embedded in symptoms checkers and 
apps/websites providing medical information, although in two cases 
(Covid19check in Malta and Corona-datenspende in Germany) symptom 
checkers do not provide users with personalised recommendations based 
on their responses to the questionnaire. Furthermore, the comparison 
revealed that only three CTAs integrate symptom checkers or medical 
information. Our analysis rather emphasised how eHealth applications 
facilitate the collection of data on the disease to the benefit of healthcare 
institutions (Q3b). This is evident for CTAs and health monitoring ap-
plications, purposely designed to trace the spread of the virus and track 
the conditions of infected individuals. However, symptom checkers also 
allow to collect geo-localised data and to monitor the diffusion of the 
disease within the territory. 
In terms of enhanced communications, only four applications allow 
citizens to directly interact with health professionals (Q4a): these are 
symptom checkers that give their users the option to call a doctor or 
arrange an appointment with their general practitioners (GPs). 
Conversely, 26 applications enabled health authorities to communicate 
with end-users (Q4b), either through automatic notifications (in the case 
of CTAs) or phone calls (triggered by health professionals monitoring 
the health conditions of patients). 
In terms of control over the service, the comparison highlighted that 
just one application is mandatory (Kwarantanna domowa in Polonia), 
limited to users who tested positive and are self-isolating (Q5a). This and 
Karantinas in Lithuania are also the only applications that do not allow 
any control from their users (Q5b), consistent with their monitoring 
function. In the other cases, citizens can exert some form of control over 
the application: for example, users of CTAs can interrupt the app by 
switching off their Bluetooth signal and symptom checkers are only 
compiled on the initiative of their users. 
Similarly, most of these applications enhance the personalisation of 
personalised healthcare services (Q6). In fact, symptom checkers, CTAs 
and health monitoring apps provide recommendations and treatments 
that reflect the personal information collected by or inputted in these 
applications. Likewise, movement monitoring apps only target those 
individuals who tested positive. However, neither the symptom checker 
developed in Malta nor the health monitoring app adopted in Germany 
delivers personalised recommendations. Likewise, information portals 
generally provide generic information, even though the use of AI- 
enabled chatbots can help to personalise this service (e.g., the case of 
Suvi in Estonia). 
As summarised in Fig. 1, e-government services are also expected to 
enhance the participation of citizens to democracy by favouring their 
inclusion in the decision-making processes, their access to updated in-
formation and the transparency of the public sector. Within the EEA, 2/3 
of the applications were developed by public institutions in partnership 
with private companies (Q7a). The latter included either small appli-
cation developers or large corporations in the ICT industry. Given their 
role as gatekeepers of apps marketplaces and mobile operating systems, 
Apple and Google inevitably influenced the design of smartphone ap-
plications and contributed to the design of certain CTAs such as the NHS 
Covid-19 app in the UK. In only two cases, communities of citizens (with 
tech expertise) were directly involved in the design of the applications. 
However, 23 smartphone apps (out of 44) have been identified as 
designed according to the principle of open-source software (Q7b). The 
latter implies that the source code of the app is made publicly available 
so that third parties can detect and fix technical issues or develop en-
hancements. This is expected to facilitate the engagement of citizens in 
policymaking by favouring their involvement in the design of e-gov-
ernment services (Linders, 2012). Furthermore, the adoption of open- 
source principles increases the transparency of the public sector. 
The latter dimension has been also assessed in relation to the storage 
of personal data and the design of algorithms. Out of 24 applications 
storing the data centrally, only two do not disclose who oversees this 
(Q8a). As to the transparency over the algorithms embedded in eHealth 
applications, CTAs do not publish their algorithm but disclose the 
criteria applied to filter the contacts. Conversely, no monitoring appli-
cations and only two symptom checkers (MaladieCoronavirus in France 
and Andrija in Croatia) specified who designed the algorithms used to 
elaborate the responses of users and provide personal recommendations. 
From the perspective of well-informedness, it is reasonable to assume 
that eHealth applications improve the quality and quantity of informa-
tion available to citizens on the pandemic and the public responses put 
in place. This naturally applies to those apps and websites providing 
updates on the evolution of the disease and the measures adopted at the 
national and local levels to contain the contagion. However, some 
symptoms checkers and all CTAs (apart from the Icelandic one) do not 
include this functionality (Q9). 
As to the other two dimensions identified by Jørgensen and Bozeman 
(2007), legality and equity, the case study analysis explored the pro-
tection of individual rights, the equality of treatment across different 
social groups and the fairness of access to these eHealth services. 
Consistent with extant literature on eHealth applications, we focused on 
privacy rights and potential barriers to eHealth adoption that could 
compromise equal access to health services (Murray et al., 2016, Mizera- 
Pietraszko & Świątek, 2015, Choi & DiNitto, 2013). 
As mentioned in Section 1 and 2, privacy has been widely debated in 
relation to CTAs. Across the sample, all the apps (except Smittestopp in 
Norway and StopCovid in France) have opted for the decentralised 
model (Q10a), which is considered more compliant with data protection 
law as data on potential contacts are solely stored on the phones of the 
users for a limited amount of time (Savona, 2020). However, our 
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analysis revealed that the protection of personal data is not at risk only 
within CTAs. Monitoring apps and symptoms checkers also collect per-
sonal data, generally stored for a long period well beyond Covid-19 
pandemic (Q10b). For example, the data collected by HSE Covid-19 
Patient Management in Ireland are to be stored for eight years, while 
the responses input in The Corona Check (the symptom checker devel-
oped by Dutch hospitals) are to be kept for 20 years. 
A further issue emerging from this comparison is the risk of 
discriminating against different groups of users or creating inequalities 
in the access to healthcare services. Whereas CTAs are deployed at a 
national level, the sample also includes symptom checkers and moni-
toring apps developed by regional authorities and only integrated with 
the regional healthcare system (Q11a). As a result, citizens from the 
same country receive different services based on the regions where they 
reside. The analysis also highlighted that 22 applications are solely 
available in the official language(s): this has been recognised as a major 
barrier to access eHealth for patients that are non-native speakers 
(Q11b). 
Likewise, in 20 cases the users of these applications are requested to 
register with the IDs provided by national or regional authorities (12a). 
This automatically excludes from the use of the applications those in-
dividuals who are not officially registered as they may be temporarily or 
illegally residing in a country. Another major impediment to equitable 
access to these services is linked to the technology used to deliver them 
(12b). Thirty-one of these eHealth services are only available via 
smartphone apps and often only work on the most recent versions of 
mobile operating systems: for example, while over 1.7 million people 
have downloaded the NHS Covid app in the UK (Kelion, 2021), the app 
cannot be downloaded on smartphones with operating systems older 
than iOS 13.5 or Android 6. As a result, users without smartphones or 
with older models are unable to benefit from these critical applications. 
6. Discussion 
The analysis in Section 5 highlighted how several eHealth applica-
tions have been adopted across the EEA since the outbreak of Covid-19. 
The case studies suggested that they can improve the administration of 
public healthcare by facilitating the dissemination and collection of 
information on the spread of Covid-19. However, the overall public 
value of these applications is sometimes affected by endogenous or 
exogenous factors (summarised in Table 2) that undermine the ability of 
eHealth applications to improve the quality of healthcare services and 
social wellbeing. 
The former reflects shortcomings in the design of eHealth applica-
tions that affect their user orientation and ability to maximise partici-
pation, legality, and equity. For example, the analysis revealed that only 
two symptom checkers allow their users to directly communicate with 
healthcare professionals (Q4a) and one does not even provide person-
alised recommendations (Q6). This undermines the potential of these 
applications to provide faster access to personal medical services. 
Likewise, the participation of citizens could be further enhanced by 
adopting open-source software principles (Q7b), currently limited to 23 
apps, or disclosing the criteria used by the algorithms embedded in 
symptom checkers and chatbots (Q8b). The developers of eHealth ap-
plications should also pay more attention to those factors that may lead 
to the exclusion of some users: within the sample, only 16 applications 
were available in a non-official language (Q11b) and 20 requested na-
tional or regional IDs to login (Q12b), thereby discriminating against 
non-native speakers and unregistered residents. 
Alongside these endogenous issues, our comparison highlighted that 
the public value of eHealth applications in the context of Covid-19 is also 
undermined by exogenous factors, reflecting market failures in the 
digital ecosystem and the potential trade-off existing between individual 
rights and public interest. The latter affects the ‘legality’ of eHealth 
applications, while the former impact on both the ‘participation of cit-
izens’ and the ‘equity’ of these services. 
The analysis confirmed that the design of eHealth applications has 
been primarily led by public agencies in partnership with technology 
providers, while the involvement of citizens has been negligible (Q7a). 
The adoption of open-source software principles may mitigate this, but 
there is little that health authorities can do to counterbalance the power 
of big players like Apple and Google in the digital ecosystem. Given their 
control over app marketplaces and operating systems for smartphones, 
these two companies have exerted significant influence over the design 
and interoperability of CTAs. The involvement of corporations in the 
development of eHealth applications raise more general concerns on the 
interference of private interests in the management of public healthcare, 
as previously noted by Hellberg and Johansson (2017). 
Furthermore, the public value of eHealth services is undermined by 
structural inequalities in the access and usage of digital technologies 
(the so-called digital divide). This implies that many are not equipped 
with the devices and/or skills needed to benefit from eHealth applica-
tions (Q12a). Quite worryingly, these issues mostly affect those social 
groups (elderly people, deprived households, migrants) that are most 
exposed to Covid-19 (Davis, 2020). Therefore, despite providing most 
citizens with better access to medical information and tailored medical 
treatments, these technologies may exacerbate inequalities in the access 
to healthcare services and undermine the universality of public 
healthcare. 
Finally, our analysis highlighted a potential trade-off between the 
individual right to privacy and the public value that can be derived from 
the collection of personal data. Whereas the risks of CTAs in this context 
have been largely discussed and generally minimised (by adopting a 
decentralised model and complying with GDPR), our comparison 
showed that symptoms checkers and health-monitoring apps also pose a 
threat to the privacy of their end-users as they collect a significant 
amount of sensitive information often stored for a long period (Q10b) 
and shared with third parties (Q10c). The latter is likely to create value 
for the public by enabling both healthcare providers to track the 
contagion and researchers to further study this disease. However, this 
may clash with the rights of individual users, especially if the latter are 
not fully aware of why their personal data are being collected and how 
these are going to be used. 
Consequently, our analysis confirmed the concerns over the fairness 
and legality of the eHealth strategies developed in response to the 
Table 2 
Factors affecting the public value of eHealth applications.   
Endogenous Factors Exogenous Factors 
User 
orientation  
• SCs and CTAs do not enable 
direct communication between 
end-users and healthcare 
professionals  
• CTAs do not integrate symptom 
checkers or information 
updates on the disease  
• SCs do not provide personalised 
information  
Participation  • Closed source software  
• Lack of transparency on the 
algorithms used in SCs and 
HMAs  
• Market power of digital 
platforms 
Legality  • Centralised model for data 
storage  
• Lack of transparency on the 
governance of personal data  
• The application is not available 
at a national level  
• The application is not available 
in non-official languages  
• Trade-off between 
individual right to privacy 
and public value of big 
data. 
Equity  • The service can only be 
accessed by inserting a personal 
ID.  
• Structural inequalities in 
the access to digital 
technologies. 
Source: Developed by authors based on the analysis of the case studies in Ap-
pendix 2. 
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current pandemic (McDonald, 2020; Savona, 2020). The comparison 
clarified that such limitations result from either shortcoming in the 
design of these applications or structural failures in the digital 
ecosystem. It must be emphasised that the issues of the legality and 
fairness of eHealth services are not only driven by ethical consider-
ations: any factor that hampers the adoption of these applications is also 
likely to undermine their effectiveness. In fact, the latter is often affected 
by the number of individuals using these services. This is well evidenced 
by the CTA developed in Norway that was launched in April 2020 but 
suspended two months later since most of the population refused to 
download it due to privacy concerns. 
Our findings also have several theoretical implications. As discussed 
in Section 3, the public value of eHealth applications can be assessed 
against a wide range of dimensions. Whereas the latter is often presented 
as complementary, this study suggests that tensions may exist among 
different dimensions of public value. Whereas the need to make public 
healthcare more efficient and more responsive pushes towards a broader 
usage of eHealth applications, the latter do not necessarily result in 
‘improved social value and wellbeing’. 
As noted above and visualised in Fig. 2, the ability of eHealth ap-
plications to deliver timely healthcare services largely depend on what 
degree these applications facilitate the retrieval of information and 
enable direct communication between users and health professionals (as 
shown in Fig. 2, circle 1). The ease of information retrieval is enhanced 
by the personalisation of medical services (made possible by the 
collection of personal data) and the possibility for the users to control 
their health status without depending on the availability of health pro-
fessionals (Fig. 2, circle 2). 
The timeliness of eHealth services arguably reduces the travel and 
time costs to access healthcare: for example, individuals using symptom 
checkers no longer need to take time off work to visit a GP, as they can 
receive diagnosis and recommendations through an app (EXPH, 2019). 
However, the overall relationship between eHealth and cost remains 
ambiguous as noted above and highlighted in Fig. 2 (circle 3). In fact, the 
Fig. 2. A revised framework for the public value of eHealth applications. 
Source: Developd by the authors, based on Jørgensen and Bozeman (2007), Scott et al. (2016), Twizeyimana and Andersson (2019) and the findings from the case 
study analysis. 
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use of digital devices and online services may entail hidden costs for the 
end-users, as they need to use their own connectivity or buy a specific 
device to access these services. Furthermore, the value of personal data 
should also be considered when estimating the cost of e-health for the 
end-users (de Lecuona & Villalobos-Quesada, 2018). 
The collection of personal data may also harm the right of citizens, 
with specific regard to privacy (Fig. 2, circle 4). More generally, the 
individual rights of citizens may be threatened by inequalities in the 
access to eHealth services, reflecting the fact that users without digital 
skills and digital devices are unable to use these services (Fig. 2, circle 
5). The exclusion of those citizens compromises the equality of treat-
ment in public healthcare and undermines the universal right to access 
medical services, thereby failing to improve social value and wellbeing 
(Fig. 2, circle 6). 
Open-source principles can help mitigate these trade-offs. As shown 
in Fig. 2 (cicle 7), by enabling citizens to contribute to the design of 
public services, the open-source approach is expected to favour the 
development of eHealth applications that preventively address those 
obstacles leading to the unfair treatment of individuals (such as a lan-
guage barriers). The open-source approach also increases the trans-
parency of the public sector, which in turn augments the well- 
informedness of citizens and reinforces the protection of individual 
rights, as shown in Fig. 2 (circle 8). In fact, the transparency of data 
collection and storage are essential to safeguard privacy rights (Marelli 
et al., 2020). Furthermore, well-informedness contributes to ensuring 
the equal treatment of healthcare users, by enhancing the quality and 
quantity of information available to citizens on the pandemic and the 
public responses put in place. However, structural failures in the market 
of digital platforms remain an unsolved issue that affects the public 
value of eHealth applications but cannot be addressed solely by health 
authorities. 
7. Conclusion 
Given the ubiquity and the enabling role of ICT across industries and 
societies, Covid-19 would not be the last time CTAs and other eHealth 
applications would be used to combat a pandemic. This is consistent 
with Hakmeh et al. (2021), who argues that Covid-19 pandemic has 
underlined the need for businesses and governments to reinvent them-
selves through the integration of digital technology or risk falling behind 
the global landscape. This is exemplified in the UK where NHS GPs are 
using technology to contact people and schedule Covid-19 vaccination 
appointments. However, our analysis highlighted that some limitations 
exist that may hamper the public value of technological applications. 
Alongside shortcomings in their design, eHealth applications are 
affected by exogenous factors, reflecting structural inequalities in the 
usage of ICT (such as the digital divide), path dependencies in the digital 
economy (due to the market power of digital platforms) and trade-offs 
between individual rights and public interest in the use of personal 
data. Speaking of digital divide, Hernández-Orallo et al. (2020) and 
Kretzschmar et al. (2020) revealed that without the inclusion of a sig-
nificant proportion of the population, contact-tracing with technology 
will be ineffective. 
Going forward, policymakers should bear in mind that while the use 
of eHealth applications can mitigate the inefficiency of traditional 
contact-tracing and enhance the delivery of healthcare services, certain 
limitations exist that need to be tackled to maximise their impact in 
terms of social value and wellbeing. Consequently, eHealth applications 
should be designed to enhance their accessibility, for example by 
allowing multiple users to access them from the same device or making 
them available on older smartphones. eHealth services should also be 
provided in the languages most frequently spoken within the country by 
ethnic minorities or the largest communities of migrants to expand their 
adoption among these social groups. Making eHealth applications 
interoperable would also allow tourists and expatriates to access and use 
these services from different regions or countries. Furthermore, the 
open-source principle should be applied more consistently in the 
attempt to make these applications more inclusive and transparent. 
Higher transparency should be guaranteed on the usage of personal data 
and the paternity of algorithms. All eHealth applications, and not just 
CTAs, should comply with GDPR to make sure that their users are fully 
aware of how their data are used, stored, transferred, and shared. 
From a theoretical perspective, this study confirms that the public 
value theory offers a solid framework to analyse e-government services, 
but also highlights the complexity of the relationships among the 
different dimensions of public value in the context of healthcare provi-
sion. This aspect needs to be further explored from both an empirical 
and theoretical perspective to clarify how eHealth applications can 
create value for the public without undermining the rights and benefits 
of individual users and marginalised groups. Further research is also 
needed to understand how failures in the digital ecosystem can be 
addressed to minimise their effects on the design and delivery of eHealth 
services. 
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Mizera-Pietraszko, J., & Świątek, P. (2015). Access to eHealth language-based services for 
multinational patients, paper presented at 17th International Conference on E-health 
Networking, Application & Services (HealthCom), Boston (MA). 
Moore, M. (1995). Creating public value: Strategic management in government. Cambridge 
(MA): Harvard University Press.  
Moore, M. (2000). Managing for value: Organizational strategy in for-profit, nonprofit, 
and governmental organizations. Nonprofit and Voluntary Sector Quarterly, 29(1_ 
suppl), 183–204. 
Murray, E., Hekler, E. B., Andersson, G., Collins, L. M., Doherty, A., Hollis, C., … 
Wyatt, C. J. (2016). Evaluating digital health interventions: Key questions and 
approaches. American Journal of Preventive Medicine, 51(5), 843–851. 
Oh, H., Rizo, C., & Enkin, M. (2005). Jadad, Alejandro What is eHealth (3): A systematic 
review of published definitions. Journal of Medical Internet Research, 7(1), e1. 
Open government partnership. (2020). Collecting open government approaches to 
COVID-19. Retrieved May 20, 2020, from https://www.opengovpartnership.org/c 
ollecting-open-government-approaches-to-covid-19/. 
Rose, J., Persson, J. S., Heeager, L. T., & Irani, Z. (2015). Managing e-government: Value 
positions and relationships. Information Systems Journal, 25(5), 531–571. 
Savona, M. (2020). The Saga of the Covid-19 contact tracing apps: Lessons for data 
governance. 2020-10 pp. 1–12). SPRU Working Paper Series (SWPS). 
Scott, M., DeLone, W., & Golden, W. (2016). Measuring eGovernment success: A public 
value approach. European Journal of Information Systems, 25(3), 187–208. 
Seltsikas, P., & O’Keefe, R. M. (2010). Expectations and outcomes in electronic identity 
management: The role of trust and public value. European Journal of Information 
Systems, 19(1), 93–103. 
Storeng, K. T., & de Bengy Puyvallée, A. (2021). The smartphone pandemic: How big 
tech and public health authorities partner in the digital response to Covid-19. Global 
Public Health, 1–17. 
Svejvig, P., Schlichter, B. R., & Andersen, P. (2012). From business IT value to public IT 
value–an action research study of healthcare in the Faroe Islands. In MCIS 2012 
Proceedings (p. 18). 
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